drugset / Trial / NCT01296035
Panitumumab and Gemcitabine in Relapsed Ovarian Cancer
NaSingle-groupOpen-labelTreatment
Summary
This is a study to find out if the study drug, panitumumab, when given with gemcitabine works in treating ovarian cancer and to find out what side effects occur when they are given together.
Timeline
- Start
- 2011-02
- Primary completion
- 2013-10
- Completion
- 2013-11
Outcome
Outcome not reported
Stopped (Enrollment): “Newer technologies available; poor accrual to study.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Gemcitabine | Small molecule | 800 mg/m2 | — |
| Subject | Panitumumab | Monoclonal antibody | 2.5 mg/kg | — |